Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

China flag China · Delayed Price · Currency is CNY
96.00
-3.69 (-3.70%)
At close: Apr 29, 2026
-14.78%
Market Cap 13.73B
Revenue (ttm) 663.57M
Net Income (ttm) 202.44M
Shares Out 137.75M
EPS (ttm) 1.47
PE Ratio 67.91
Forward PE n/a
Dividend 0.80 (0.80%)
Ex-Dividend Date May 29, 2025
Volume 854,036
Average Volume 571,657
Open 100.79
Previous Close 99.69
Day's Range 95.50 - 100.79
52-Week Range 92.57 - 132.94
Beta 0.26
RSI 43.68
Earnings Date Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 670
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688198
Full Company Profile

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.

Financial Statements

News

There is no news available yet.